Viatris Inc.
NASDAQ:VTRS · NASDAQ Global Select
-$0.36 today
Vol 19.55M · Avg 10.58M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+80.40%
Period High
$17.26
Period Low
$8.41
Latest
$15.37
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Moderna, Inc.
NASDAQ:MRNA
$25.38B
Roivant Sciences Ltd.
NASDAQ:ROIV
$22.59B
Exact Sciences Corporation
EXAS
$20.03B
Neurocrine Biosciences, Inc.
NASDAQ:NBIX
$15.92B
BridgeBio Pharma, Inc.
NASDAQ:BBIO
$12.98B
Ionis Pharmaceuticals, Inc.
NASDAQ:IONS
$12.25B
Elanco Animal Health Incorporated
NYSE:ELAN
$12.10B
Dr. Reddy's Laboratories Limited
NYSE:RDY
$11.07B
Baxter International Inc.
NYSE:BAX
$10.28B
Regencell Bioscience Holdings Limited
NASDAQ:RGC
$5.94B
What is the latest VTRS filing?
The latest filing shown is 424B5 dated Jun 15, 2026.
How many recent filings does VTRS have?
Intrinsic Alpha currently shows 20 recent filings for VTRS.
Explore More
Continue the stock analysis
Jump to another research area for this company.